QNCX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	163 013
Średni wolumen	79 516.00
Kapitalizacja rynkowa	38.89M
EPS	$0 ( 2024-05-20 )
Następna data zysków	( $0 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.070
ATR14	$0.00800 (0.91%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-15	Patni Rajiv	Buy	54 000	Employee Stock Option (right to buy)
2024-02-15	Patni Rajiv	Buy	0
2024-02-01	Ryan Charles S.	Buy	145 000	Employee Stock Option (right to buy)
2024-02-01	Hannah Brendan	Buy	600 000	Employee Stock Option (right to buy)
2024-02-01	Thye Dirk	Buy	1 500 000	Employee Stock Option (right to buy)

INSIDER POWER
89.96
Last 72 transactions
Buy: 5 607 188 \| Sell: 249 899

Wolumen Korelacja

Długi: -0.12 (neutral)

Krótki: -0.43 (neutral)

Signal:(36.805) Neutral

Quince Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Quince Therapeutics, Inc. Korelacja - Waluta/Towar

-0.61
( weak negative )

-0.59
( weak negative )

0.00
( neutral )

-0.63
( weak negative )

0.00
( neutral )

0.61
( weak )

Quince Therapeutics, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-322 000 (0.00 %)
EPS:	$-0.840

FY	2023
Przychody:	$0
Zysk brutto:	$-322 000 (0.00 %)
EPS:	$-0.840

FY	2022
Przychody:	$0
Zysk brutto:	$-175 000 (0.00 %)
EPS:	$-1.540

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.02

Financial Reports:

No articles found.

Quince Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Quince Therapeutics, Inc.

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.